Results 101 to 110 of about 2,054,122 (239)
Background: Atrial fibrillation (AF) has been identified as a risk factor for functional tricuspid regurgitation (FTR) in the absence of other known etiologies, although limited interventional options are available.
Da-Wei Lin +10 more
doaj +1 more source
ABSTRACT Background Transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve (BAV) anatomy remains challenging due to anatomical complexity and limited trial data. New‐generation balloon‐expandable valves, such as Myval, require further evaluation in this subgroup.
Balázs Magyari +11 more
wiley +1 more source
Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry. [PDF]
AIMS T-TEER is an effective therapy for the treatment of tricuspid regurgitation (TR). However, the effects of leaflets clipping on tricuspid valve annulus (TA) have not been investigated in detail.
Maisano, Francesco +36 more
core +1 more source
First-in-Human Transcatheter Tricuspid Valve Repair in a Patient With Severely Regurgitant Tricuspid Valve [PDF]
BackgroundSevere tricuspid regurgitation is associated with poor prognosis; however, there are limited Class I indications for intervention, and high–surgical risk patients may go untreated. We report the first-in-human successful transcatheter tricuspid
Tiburtius, Claudia +5 more
core +1 more source
Transcatheter Treatment of Tricuspid and Mitral Regurgitation: Similar Path, Different Stages
: Tricuspid regurgitation (TR) is frequently detected, especially in its secondary form, while primary TR is far less frequent. Similar to mitral regurgitation (MR), primary tricuspid regurgitation should require timely intervention to avoid secondary ...
Maisano, Francesco +2 more
core +1 more source
Background: Tricuspid regurgitation (TR) frequently occurs as a functional complication of perimembranous ventricular septal defect (pmVSD) in pediatric patients.
Ahmed El-Emam +4 more
doaj +1 more source
Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk. Recently, numerous new medical devices have been proposed and approved for use.
Eugenia Piragine +4 more
openaire +3 more sources
Tricuspid regurgitation (TR) affects over 1.6 million individuals in the United States, with a one-year mortality rate of 36.1% and a five-year survival below 30%.
Asad Gul Rao +3 more
doaj +1 more source
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation [PDF]
BACKGROUND: Severe tricuspid regurgitation is associated with disabling symptoms and an increased risk of death. Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed.
Sharma, Rahul P +33 more
core +3 more sources
Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)- systematic review and meta-analysis [PDF]
The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading ...
Webb, J +21 more
core +2 more sources

